Am J Gastroenterol
- HIRODE G, Hansen BE, Chen CH, Su TH, et al
Limited sustained remission after nucleos(t)ide analogue withdrawal: Results from
a large, global, multi-ethnic cohort of patients with chronic hepatitis B
(RETRACT-B study).
Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002759.
Eur J Gastroenterol Hepatol
- YUKSEKYAYLA O, Kina N, Ulaba A, Emin Ergun M, et al
The frequency and clinical significance of antibodies to soluble liver
antigen/liver pancreas in autoimmune hepatitis: a prospective single-center
study.
Eur J Gastroenterol Hepatol. 2024 Mar 4. doi: 10.1097/MEG.0000000000002747.
Hepatology
- TIAN F, Forouzannia F, Feng Z, Biondi MJ, et al
Feasibility of hepatitis C elimination by screening and treatment alone in
high-income countries.
Hepatology. 2024 Mar 13. doi: 10.1097/HEP.0000000000000779.
J Hepatol
- JACHS M, Sandmann L, Hartl L, Tergast T, et al
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms
for clinically significant portal hypertension in hepatitis delta.
J Hepatol. 2024 Mar 11:S0168-8278(24)00156-9. doi: 10.1016/j.jhep.2024.
- SEITZ S, Bartenschlager R
Cutting edges in the hepatitis B virus genome: How RNA splicing is involved in
modulating virus ultrastructure to promote infection.
J Hepatol. 2024 Mar 7:S0168-8278(24)00148-X. doi: 10.1016/j.jhep.2024.
- SIMSEK C, Wahlin S, Efe C
Autoimmune Hepatitis: Mycophenolate mofetil versus azathioprine as first line
therapy.
J Hepatol. 2024 Mar 6:S0168-8278(24)00142-9. doi: 10.1016/j.jhep.2024.
J Infect Dis
- KAMILI S, Wester C
Advancing diagnosis of current HCV infection: A key to hepatitis C elimination in
the United States.
J Infect Dis. 2024 Mar 11:jiae127. doi: 10.1093.
J Med Virol
- WANG LT, Chen YH, Cheng Y, Fan HL, et al
Clinical implications of hepatitis B virus core antigen-mediated immunopathologic
T cell responses in chronic hepatitis B.
J Med Virol. 2024;96:e29515.
- YANG J, Xu S, Cheng J, Yin X, et al
CXCL10 and its receptor in patients with chronic hepatitis B and their ability to
predict HBeAg seroconversion during antiviral treatment with TDF.
J Med Virol. 2024;96:e29516.
J Viral Hepat
- NAVEED A, Khalid A, Janjua N, Cloherty GA, et al
Performance of HCV core antigen and PCR testing in a predominantly genotype 3
population.
J Viral Hepat. 2024 Mar 14. doi: 10.1111/jvh.13937.
- DOBROWOLSKA K, Pawlowska M, Zarebska-Michaluk D, Rzymski P, et al
Direct-acting antivirals in women of reproductive age infected with hepatitis C
virus.
J Viral Hepat. 2024 Mar 14. doi: 10.1111/jvh.13936.
PLoS One
- NOMBOT-YAZENGUET MPM, Modiyinji AF, Tricou V, Manirakiza A, et al
Investigating animal reservoirs for hepatitis E virus in Bangui, Central African
Republic.
PLoS One. 2024;19:e0300608.
- YEN YH, Kee KM, Hu TH, Tsai MC, et al
Hepatitis B virus-related hepatocellular carcinoma has superior overall survival
compared with other etiologies.
PLoS One. 2024;19:e0290523.
- TEPJANTA P, Fujiyama K, Misaki R, Kimkong I, et al
The N-linked glycosylation modifications in the hepatitis B surface protein
impact cellular autophagy, HBV replication, and HBV secretion.
PLoS One. 2024;19:e0299403.
PLoS Pathog
- MATSUDA M, Hirai-Yuki A, Kotani O, Kataoka M, et al
Loxapine inhibits replication of hepatitis A virus in vitro and in vivo by
targeting viral protein 2C.
PLoS Pathog. 2024;20:e1012091.
- LI Y, Wu C, Lee J, Ning Q, et al
Hepatitis B virus e antigen induces atypical metabolism and differentially
regulates programmed cell deaths of macrophages.
PLoS Pathog. 2024;20:e1012079.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016